James DArecca
CIK 1583903 · EVP, Chief Financial Officer · last filed 2026-08-05
James DArecca is an EVP, Chief Financial Officer who has filed 42 SEC Form 4 insider transactions across 5 companies since 2015. The most recent filing, for PBH, was dated Aug 5, 2026. Across all open-market trades the lifetime net is −$81.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.2M across reported positions. 23 SEC filings were submitted jointly with Actavis plc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.24M
5
42
-$81.2K
Filer Profile
125 SUMMER STREET
BOSTON, MA 02110
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBH | Director | 9,572 | $46.37 | $443.9K | $0 | 4 | 2026-08-05 |
| HAE | EVP, Chief Financial Officer | 54,444 | $105.36 | $5.74M | $0 | 13 | 2026-05-19 |
| TXMD | Chief Financial Officer | 4,343 | $2.06 | $8.9K | -$81.2K | 4 | 2021-08-12 |
| Allergan plc (AGN) Delisted | SVP Chief Accounting Officer | 0 | — | — | $0 | 18 | 2020-05-11 |
| ACT | CHIEF ACCOUNTING OFFICER | 1,182 | $47.01 | $55.6K | $0 | 2 | 2015-03-09 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-05 | PBH | Grant (A) | +2,981 | $0 | EDGAR |
| 2026-05-19 | HAE | Mixed | +26,807 | -$141.0K | EDGAR |
| 2026-05-05 | HAE | Tax (F) | −655 | -$38.8K | EDGAR |
| 2025-08-06 | PBH | Grant (A) | +2,094 | $0 | EDGAR |
| 2025-06-03 | HAE | Mixed | +6,357 | -$406.8K | EDGAR |
| 2025-05-20 | HAE | Grant (A) | +7,111 | $0 | EDGAR |
| 2025-05-19 | HAE | Tax (F) | −1,868 | -$130.8K | EDGAR |
| 2025-05-05 | HAE | Tax (F) | −654 | -$41.8K | EDGAR |
| 2024-08-07 | PBH | Grant (A) | +2,202 | $0 | EDGAR |
| 2024-05-21 | HAE | Grant (A) | +4,439 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.